Gene therapy for surfactant protein B deficiency using recombinant AAV

Gene therapy for surfactant protein B deficiency using recombinant AAV

Bibliographic Details
Main Authors:	Meyer-Berg, H, Hyde, S, Gill, D
Format:	Conference item
Published:	Elsevier 2019

Similar Items

Gene therapy for surfactant protein B deficiency using recombinant AAV vectors
by: Meyer-Berg, H
Published: (2021)

A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications
by: Munis, AM, et al.
Published: (2020)

Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
by: Meyer-Berg, H, et al.
Published: (2020)

Development of recombinant Adeno-Associated Viral vector (rAAV) for passive immunisation against ebola
by: Tan, T, et al.
Published: (2017)

Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques
by: Liam Cole, et al.
Published: (2021-04-01)

Efficient gene transduction in pigs and macaques with the engineered AAV vector AAV.GT5 for hemophilia B gene therapy
by: Yuji Kashiwakura, et al.
Published: (2023-09-01)

Immunogenicity and toxicity of AAV gene therapy
by: Hildegund C. J. Ertl
Published: (2022-08-01)

AAV gene therapy vectors in the TMJ
by: Sabine M. Brouxhon, et al.
Published: (2022-12-01)

An AAV-Based NF-κB-Targeting Gene Therapy (rAAV-DMP-miR533) to Inflammatory Diseases
by: Luo T, et al.
Published: (2022-06-01)

Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
by: Reetta A. E. Eriksson, et al.
Published: (2022-12-01)

Allometric-like scaling of AAV gene therapy for systemic protein delivery
by: Alexandra Burr, et al.
Published: (2022-12-01)

Adding recombinant AAVs to the cancer therapeutics mix
by: Patrick L. Mulcrone, et al.
Published: (2022-12-01)

Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
by: Reetta A. E. Eriksson, et al.
Published: (2023-03-01)

Editorial: Immunogenicity and toxicity of AAV gene therapy
by: Allison Bradbury, et al.
Published: (2023-06-01)

Variation in the surfactant protein B gene is associated with development of emphysema in alpha 1 anti-trypsin deficiency
by: Wood, A, et al.
Published: (2007)

Robust AAV Genotyping Based on Genetic Distances in Rep Gene That Are Maintained by Ubiquitous Recombination
by: Marina I. Beloukhova, et al.
Published: (2022-05-01)

Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting
by: Christopher Chan, et al.
Published: (2023-10-01)

Optimizing an AAV-CRISPR system for retinal gene therapy
by: Stevanovic, M
Published: (2019)

Choroideremia: molecular mechanisms and development of AAV gene therapy
by: Patrício, M, et al.
Published: (2018)

AAV for Gene Therapy in Ocular Diseases: Progress and Prospects
by: Xiaoyu He, et al.
Published: (2023-01-01)

AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy
by: Ridhwaanah Jacobs, et al.
Published: (2023-12-01)

Evaluation of AAV-DJ vector for retinal gene therapy
by: Yusaku Katada, et al.
Published: (2019-01-01)

Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy
by: Miranda Gehrke, et al.
Published: (2022-06-01)

Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
by: Shaza S. Issa, et al.
Published: (2023-03-01)

Inclusion of PF68 surfactant improves stability of rAAV titer when passed through a surgical device used in retinal gene therapy
by: Patrício, M, et al.
Published: (2019)

Cell-mediated inflammatory response to AAV gene therapy in the retina
by: Chandler, LC, et al.
Published: (2020)

Gene Therapy for Choroideremia Using an Adeno-Associated Viral (AAV) Vector.
by: Barnard, A, et al.
Published: (2014)

Development of an icIEF assay for monitoring AAV capsid proteins and application to gene therapy products
by: Xiaoping Z. He, et al.
Published: (2023-06-01)

Gene Therapy Using Recombinant AAV Type 8 Vector Encoding TNAP‐D10 Improves the Skeletal Phenotypes in Murine Models of Osteomalacia
by: Flavia Amadeu de Oliveira, et al.
Published: (2023-01-01)

Mannose-coupled AAV2: A second-generation AAV vector for increased retinal gene therapy efficiency
by: Mathieu Mével, et al.
Published: (2024-03-01)

Development of AAV-mediated gene therapy for autosomal recessive bestrophinopathy
by: Wood, S
Published: (2017)

Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
by: Marina Pavlou, et al.
Published: (2021-04-01)

Intramuscular rAAV2/8 mediated expression of etanercept in mice with collagen-induced arthritis
by: Habib, O, et al.
Published: (2019)

AAV-based gene therapy ameliorated CNS-specific GPI defect in mouse models
by: Yoshiko Murakami, et al.
Published: (2024-03-01)

Genes polymorphism of surfactant protein B and respiratory morbidity in preschoolers
by: O. Mazulov, et al.
Published: (2017-06-01)

Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
by: Ail D, et al.
Published: (2023-05-01)

Effect of protein A-immunoadsorption therapy on serum cytokines in AAV patients
by: Li, Xiejia, et al.
Published: (2022)

Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays
by: Thilo M. Buck, et al.
Published: (2020-06-01)

AAV2-antiVEGFscFv gene therapy for retinal neovascularization
by: Ni Han, et al.
Published: (2023-12-01)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
by: Antepowicz, A, et al.
Published: (2021)